Skip to main content
Journal cover image

Detection of mutations in homologous recombination repair (HRR) genes in tumour tissue (TT) and circulating tumour DNA (ctDNA) from patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) in the phase III PROpel trial

Publication ,  Conference
Armstrong, AJ; Saad, F; Thiery-Vuillemin, A; Oya, M; Shore, ND; Mehra, N; Ozguroglu, M; Gedye, C; Sartor, O; Poehlein, CH; Qiu, P; Liu, Y-Z ...
Published in: ANNALS OF ONCOLOGY
2022

Duke Scholars

Published In

ANNALS OF ONCOLOGY

EISSN

1569-8041

ISSN

0923-7534

Publication Date

2022

Volume

33

Issue

7

Start / End Page

S1168 / S1168

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., Saad, F., Thiery-Vuillemin, A., Oya, M., Shore, N. D., Mehra, N., … Clarke, N. (2022). Detection of mutations in homologous recombination repair (HRR) genes in tumour tissue (TT) and circulating tumour DNA (ctDNA) from patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) in the phase III PROpel trial. In ANNALS OF ONCOLOGY (Vol. 33, pp. S1168–S1168).
Armstrong AJ, Saad F, Thiery-Vuillemin A, Oya M, Shore ND, Mehra N, Ozguroglu M, Gedye C, Sartor O, Poehlein CH, Qiu P, Liu Y-Z, Riva L, Harrington L, Barker L, Del Rosario PMD, Barnicle A, Clarke N. Detection of mutations in homologous recombination repair (HRR) genes in tumour tissue (TT) and circulating tumour DNA (ctDNA) from patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) in the phase III PROpel trial. ANNALS OF ONCOLOGY. 2022. p. S1168–S1168.
Journal cover image

Published In

ANNALS OF ONCOLOGY

EISSN

1569-8041

ISSN

0923-7534

Publication Date

2022

Volume

33

Issue

7

Start / End Page

S1168 / S1168

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis